EswarKrishnanMD

PubMed

• 62 citations
  Nature Versus Nurture in Gout: A Twin Study
  Eswar Krishnan, Christina N. Lessov-Schlaggar, Ruth Krasnow, Gary E. Swan
  The American Journal of Medicine. 2012-05-01
• 112 citations
  Factors associated with patients who leave acute-care hospitals against medical advice.
  Said A. Ibrahim, C. Kent Kwoh, Eswar Krishnan
  American Journal of Public Health. 2007-01-12
• 67 citations
  Lifestyle Risk Factors Predict Disability and Death in Healthy Aging Adults
  Eliza F. Chakravarty, Helen B. Hubert, Eswar Krishnan, Bonnie Bruce, Vijaya B. Lingala
  The American Journal of Medicine. 2012-02-01

Journal Articles

• Brief report: citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis  
  Sokolove J, Sharpe O, Brennan M, Lahey LJ, Kao AH, Krishnan E,Wasko MC, Robinson WH, Arthritis Rheum, 7/1/2013
• Upper Extremity and Mobility Subdomains from the Patient-Reported Outcomes Measurement Information System (PROMIS®) Adult Physical Functioning Item Bank  
  Hays RD, Spritzer KL, Amtmann D, Lai JS, Dewitt EM, Rothrock N, Dewalt DA, Riley WT, Fries JF, Krishnan E, Arch Phys Med Rehabil, 6/7/2013
• Serum Urate and Incidence of Kidney Disease Among Veterans with Gout  
  Krishnan E, Akhras KS, Sharma H, Marynchenko M, Wu E, Tawk RH, Liu J, Shi L, J Rheumatol, 5/15/2013
• Tophaceous gout and high level of hyperuricemia are both associated to increased risk of mortality in patients with gout  
  Perez-Ruiz F, Carmona, L Herrero-Beites AM, Pijoan JI, Krishnan E, Ann Rheum Dis, 1/12/2013
• Nature vs Nurture in gout  
  Krishnan E, Lessov-Schlaggar C, Krasnow, R, Swan, G, Am J Med, 1/1/2012
• Low level lead exposure and the risk for gout: Results from the NHANES study  
  Krishnan E, Lingala B, Bhalla V, Ann Internal Med, 1/1/2012
• Hyperuricemia in young adults and the risk for insulin resistance, prediabetes and diabetes: a 15 year follow up study  
  Krishnan E, Pandya B, Chung L, Hariri A, Dabbous O, Am J Epid, 1/1/2012
• Dutch translation and cross-cultural adaptation of the PROMIS® physical function item bank and cognitive pre-test in Dutch arthritis patients  
  Oude Voshaar MAH, ten Klooster PM, Taal E, Krishnan E, van de Laar MAFJ, Arthritis Res Ther, 1/1/2012
• Pegloticase and the patient with treatment failure gout  
  Dave A, Kelly V, Krishnan E, Expert Rev Clin Pharmacol, 1/1/2012
• Hyperuricemia and carotid artery dilatation among young adults without metabolic syndrome  
  Krishnan E, Wildman R, Cooper J, Sutton-Tyrrell K, Rheumatology Reports, 1/1/2012
• Reduced glomerular filtration and the prevalence of gout: NHANES 2009-10  
  Krishnan E, PLoS One, 1/1/2012
• Chronic kidney disease in gout in a managed care setting  
  Fuldeore MJ, Riedel AA, Zarotsky V, Pandya BJ, Dabbous O, Krishnan E, BMC Nephrol, 1/1/2011
• Disability in rheumatoid arthritis in the era of biological treatments  
  Krishnan E, Lingala B, Bruce B, Fries JF, Ann Rheum Dis, 1/1/2011
• Febuxostat for the treatment of hyperuricemia in patients with gout  
  Kelly V, Krishnan E, Int J Clin Rheumatology, 1/1/2011
• The Future of Measuring Patient-Reported Outcomes in Rheumatology  
  Khanna D, Krishnan E, Dewitt EM, Khanna PP, Spiegel B, Hays RD, Arthrit Care Res, 1/1/2011
• Hyperuricemia and the risk for subclinical coronary atherosclerosis - data from a prospective observational cohort study  
  Krishnan E, Pandya BJ, Chung L, Dabbous O, Arthritis Res Ther, 1/1/2011
• An Analysis of connective Tissue Disease-associated Interstitial Lung Disease at a US Tertiary Care Center: Better Survival in Patients with Systemic Sclerosis  
  Su R, Bennett M, Jacobs S, Hunter T, Bailey C, Krishnan E, Rosen G, Chung L, J Rheumatol, 1/1/2011
• Inflammation, oxidative stress and lipids: the risk triad of atherosclerosis in gout  
  Krishnan E, Rheumatology (Oxford), 1/1/2010
• Items, Instruments, Crosswalks, and PROMIS  
  Fries JF, Krishnan E, Bruce B, Journal of Rheumatology, 1/1/2009
• What constitutes progress in assessing patient outcomes?  
  Fries JF, Krishnan E, Journal of Clinical Epidemiology, 1/1/2009
• Cost and Risk of Gout Flares among the Elderly: Does Serum Uric Acid Level Matter?  
  Wu E, Patel P, Yu A, Mody R, Cahill K, Tang J, Krishnan E, J Rheumatol, 1/1/2009
• Characterizing systemic sclerosis in Northern California: focus on Asian and Hispanic patients  
  Schmajuk G, Bush TM, Burkham J, Krishnan E, Chung L, Clin Exp Rheumatol, 1/1/2009
• A brief report of gout in ambulatory care settings in the United States  
  Krishnan E, Lienesch D, Kwoh CK, J Rheumatol, 1/1/2008
• Hyperuricemia: Where rheumatologist meets nephrologist  
  Avram Z, Krishnan E, Rheumatology (Oxford), 1/1/2008
• Progress in assessing disability in arthritis patients: Computerized adaptive testing (CAT)  
  Fries JF, Bruce B, Rose M, Krishnan E, Arthritis and Rheumatism, 1/1/2008
• Join now to see all

Books/Book Chapters

• Oxidative Stress in Advanced Basic Research and Clinical Practice. Studies on Arthritis and Joint Diseases. 
  Chapter: Metabolic syndrome and gout. 
  Page 237 - 250Krishnan EEditors: Alcaraz M.Springer2012
• Gout & Other Crystal Arthropathies. 
  Chapter: Epidemiology and Risk factors. 
  Page 72 - 84Krishnan EEditors: Terkeltaub R.Elsevier Saunders2011
• Rheumatic Disease Clinics of North America 
  Chapter: Musculoskeletal disorders and the national health and nutrition examination surveys (NHANES). 
  Page 869 - 878Sokka T, Krishnan EEditors: Choi HK.2004
• Targeted Therapies in Rheumatology 
  Chapter: Long-term observational studies. 
  Page 667 - 677Krishnan E, Singh G, Tugwell PEditors: Smolen J, Lipsky P.Martin Dunitz, London2003
• Shaw’s Textbook of Gynaecology 
  Chapter: Epidemiology of Gynecological cancers. 
  Day NE, Krishnan EEditors: Soutter.Churchill Livingstone, Edinburgh, Scotland1997
• Join now to see all

Abstracts/Posters

• Citrullination within the Atherosclerotic Plaque: A New Potential Target for Anti-Citrullinated Protein Antibodies.
  Sokolove J, Share O, Brennan M, Krishnan et al., Arthritis and Rheumatism, 1/1/2012
• Cost-Effectiveness of Systemic Therapies for Acute Gouty Arthritis.
  Reiter K, Goldhaber-Fiebert J, Krishnan E, Arthritis and Rheumatism, 1/1/2012
• Valdiation of a Diagnosis of Gout in the Epiccare Electronic Medical Records.
  Narang N, Krishnan E, Arthritis and Rheumatism, 1/1/2012
• Menopause and the Prevalence of Gout and Hyperuricemia: An Age-Matched Case Control Study.
  Krishnan E, Bennett M, Arthritis and Rheumatism, 1/1/2012
• Glomerular Filtration Rate, Chronic Kidney Disease and Incidence of Physician Diagnosed Gout.
  Krishnan E, Arthritis and Rheumatism, 1/1/2012
• Prevalence of Gout Among Adults with Chronic Kidney Disease in the United States, 2009-10.
  Krishnan E, Arthritis and Rheumatism, 1/1/2012
• Prevalence of Knee Pain in Ultramarathon Runners.
  Kelly VM, Hoffman M, Lingala B, Bennett M, Krishnan E, Arthritis and Rheumatism, 1/1/2012
• Excess Mortality From Atherosclerotic Cardiovascular Disease in Systemic Sclerosis Compared to Lupus and Rheumatoid Arthritis.
  Dave AJ, Lingala B, Fiorentino D, Krishnan E, Chung L, Arthritis and Rheumatism, 1/1/2012
• Uncontrolled Serum Uric Acid In Veteran Gout Patients Is Associated with a Higher Risk of Diabetes.
  Pandya BJ, Marynchenko M, Sharma H, et al., Arthritis and Rheumatism, 1/1/2011
• A Patient Reported Frailty Index That Can Predict Mortality Outcomes Among Patients with Arthritis.
  Krishnan E, Fries JF, Lingala B, Arthritis and Rheumatism, 1/1/2011
• Febuxostat vs Allopurinol in Elderly Gout Subjects: Subgroup Analysis of the CONFIRMS Trial.
  Krishnan E, MacDonald PA, Hunt BJ, Jackson RL, Journal of the American Geriatrics Society, 1/1/2011
• Uncontrolled Serum Uric Acid Is Associated with An Increased Risk of Developing Renal Disease In Veterans with Gout.
  Krishnan E, Sharma H, Pandya BJ, et al., Arthritis and Rheumatism, 1/1/2011
• International Classification of Diseases-Clinical Modification-9 Codes for the Diagnosis of Dermatomyositis and Polymyositis in Discharge Summaries: Evidence of Accept...
  Narang N, Fiorentino D, Krishnan E, Chung L, Arthritis and Rheumatism, 1/1/2011
• Efficacy and Safety of Lesinurad (RDEA594), A Novel Uricosuric Agent, Given In Combination with Allopurinol in Allopurinol-Refractory Gout Patients: Preliminary Result...
  Sundy J, Perez-Ruiz F, Krishnan E, et al., Arthritis and Rheumatism, 1/1/2011
• Hyperuricemia and the Risk for Type 2 Diabetes Mellitus and Prediabetes.
  Pandya BJ, Dabbous O, Bron M, et al., Diabetes, 1/1/2010
• Health service costs and resource utilization among managed care enrollees with gout and renal disease.
  Riedel AA, Fuldeore MJ, Braun BB, Krishnan E, Value in Health, 1/1/2008
• Hyperuricemia and the risk of isolated hypertension among young people without cardiovascular and metabolic risk factors: The CARDIA study.
  Krishnan E, Choi HK, Kuller LH, Liu K, Circulation, 1/1/2007
• Treatment cost of gout in an elderly population: A claims database analysis.
  Wu EQ, Patel PA, Krishnan E, et al., Journal of the American Geriatrics Society, 1/1/2007
• Outcomes after acute myocardial infarction in systemic lupus erythematosus as compared to diabetes mellitus.
  Shah AM, Shah MA, Krishnan E, Journal of the American College of Cardiology, 1/1/2007
• Men with gout die from acute myocardial infarction at a rate higher than expected from their traditional cardiovascular risk profile.
  Krishnan E, Svendsen K, Neaton J, Grandits G, Kuller L, Annals of the Rheumatic Diseases, 1/1/2007
• Hyperuricemia and the risk for incident hypertension among middle-aged men.
  Krishnan E, Kwoh K, Schumacher R, Kuller L, Circulation, 1/1/2007
• Hospital post-CABG mortality in patients with systemic lupus erythematosus and rheumatoid arthritis.
  Kao AH, Krishnan E, Annals of the Rheumatic Diseases, 1/1/2007
• Tighter control of serum uric acid in gout is associated with lower morbidity and health care costs.
  Wu EQ, Mody RR, Krishnan E, et al., Arthritis and Rheumatism, 1/1/2006
• Verification of ICD-CM-9 coding for the diagnosis of systemic sclerosis.
  Khurma V, Furst DE, Krishnan E, Khanna D, Arthritis and Rheumatism, 1/1/2006
• Gout among veterans in the United States: 1998-2004.
  Kent Kwoh C, Skanderson M, Krishnan E, Chen L, Schumacher R, Arthritis and Rheumatism, 1/1/2006
• Join now to see all

Lectures

• Hyperuricemia and Atherothrombotic Vascular Disease-What to Do With the Evidence? 
  Washington, DC - 1/1/2012
• Uncontrolled serum uric acid is associated with an increased risk of developing renal disease in veterans with gout. 
  1/1/2011
• An item-response theory-based approach for measuring frailty in large populations. 
  Taipei, ROC - 1/1/2011
• Towards high throughput health outcome measurement. 
  Monterey, CA - 1/1/2011
• Hyperuricemia and the Risk for Type 2 Diabetes Mellitus and Prediabetes. 
  Orlando, FL - 1/1/2010
• Progress in health outcome measurement: The PROMIS project. 
  Kansas City, KS - 1/1/2010
• Interventions for hyperuricemia sans gout: What when why and how. 
  London, UK - 1/1/2010
• Reducing sample size needs in clinical trials. 
  Borneo, Malaysia - 1/1/2010
• Hyperuricemia and the risk of isolated hypertension among young people without cardiovascular and metabolic risk factors: The CARDIA study. 
  Orlando, FL - 1/1/2007
• Tighter control of serum uric acid in gout is associated with lower morbidity and health care costs. 
  1/1/2006
• Time trends in cumulative disability in Rheumatoid Arthritis 1960-1998. 
  1/1/2001
• Join now to see all